Retired military or spouse with Tricare

Rick4407

This is new coverage for members with Tricare insurance.

For up to the next five years, TRICARE will cover Food and Drug Administration (FDA)-approved monoclonal antibodies (MABs) lecanemab (brand name Leqembi) and donanemab (brand name Kisunla), for the treatment of Alzheimer’s disease in patients with mild cognitive impairment or in the mild dementia stage of the disease. The assistant secretary of defense for health affairs approved the change last October.

I've read very mixed reviews on these treatments but it's now at least a choice… Rick